Sutureless aortic valve and post-operative atrial fibrillation: Five-year outcomes from a propensity matched cohort study

doi:10.4330/wjc.v17.i4.102669

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (25)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-3)

Sum=24

Apr 26, 2025 (publication date) through Apr 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Cardiol. Apr 26, 2025; 17(4): 102669
Published online Apr 26, 2025. doi: 10.4330/wjc.v17.i4.102669

Table 1 Cohort characteristics, median (25^th-75^th percentiles)

	Sutured (n = 808)	Perceval (n = 174)	P value
Demographics
Age (n = 982)	70 (64-76)	77 (74-80)	< 0.001
Gender (n = 982)			< 0.001
Male	520 (64.4)	70 (40.2)
Female	288 (35.6)	104 (59.8)
BMI (n = 982)	28.4 (25.0-32.4)	29.0 (25.6-32.8)	0.165
Smoking status (n = 848)			0.024
Non-smoker	334 (41.3)	65 (37.4)
Ex-smoker	279 (34.5)	76 (43.7)
Current smoker	86 (10.6)	8 (4.6)
Diabetes (n = 982)			0.002
No	659 (81.6)	124 (71.3)
Diet	38 (4.7)	7 (4.0)
Oral therapy	79 (9.8)	27 (15.5)
Insulin	32 (4.0)	16 (9.2)
NYHA grade (n = 879)			0.148
Grade I	144 (17.8)	21 (12.1)
Grade II	208 (25.7)	37 (21.3)
Grade III	282 (34.9)	69 (39.7)
Grade IV	93 (11.5)	25 (14.4)
Cardiovascular risk factors
Heart rhythm (n = 914)			0.54
Sinus rhythm	607 (80.8)	129 (79.1)
Atrial fibrillation/flutter	123 (16.4)	32 (19.6)
Complete heart block/pacing	11 (1.5)	2 (1.2)
Other dysrhythmia	9 (1.2)	0 (0.0)
Hypertension (n = 882)	511 (63.2)	126 (72.4)	0.022
CCS angina status (n = 858)			0.863
CCS0	422 (59.1)	79 (54.9)
CCS1	83 (11.6)	19 (13.2)
CCS2	95 (13.3)	23 (16.0)
CCS3	82 (11.5)	16 (11.1)
CCS4	32 (4.5)	7 (4.9)
LVEF (n = 681)			0.578
Good (> 50%)	424 (75.7)	92 (76.0)
Moderate (21%-30%)	109 (19.5)	22 (18.2)
Poor (31%-50%)	22 (3.9)	7 (5.8)
Very poor (< 25%)	5 (0.9)	0 (0.0)
Previous MI (n = 918)	62 (8.2)	12 (7.5)	0.794
Reoperation procedure (n = 982)	42 (5.2)	7 (4.0)	0.518
Risk scores
Additive Euroscore (n = 980)	5.00 (1.88-7.00)	6.00 (2.22-7.00)	0.003
Logistic Euroscore (n = 600)	5.28 (3.29-8.56)	7.01 (5.48-10.27)	< 0.001

BMI: Body-mass index; NYHA: New York Heart Association; CCS: Canadian Cardiovascular Society; LVEF: Left Ventricular Ejection Fraction; MI: Myocardial infarction.

Table 2 Intra-operative details before and after propensity matching, median (25^th-75^th percentiles)

	Before propensity score matching			After propensity score matching
	Sutured	Perceval	P value	Sutured	Perceval	P value
Bypass time (minutes) (n = 925)	93.0 (72.0-123)	60.0 (49.0-78.0)	< 0.001	87.0 (69.0-112)	60.0 (49.0-78.0)	< 0.001
Cross-clamp time (minutes) (n = 924)	75.0 (58.0-99.0)	45.5 (36.0-57.0)	< 0.001	71.0 (56.0-90.6)	45.5 (36.0-57.0)	< 0.001
Time Ventilated (hours) (n = 873)	11.5 (7.6-19.0)	9.9 (7.3-17.9)	0.383	13.6 (9.35-20.5)	9.88 (7.33-17.9)	0.005
Time in theatre (minutes) (n = 981)	180 (153-215)	139 (119-165)	< 0.001	171 (143-201)	139 (119-165)	< 0.001

Table 3 Immediate post-operative outcomes before and after propensity score matching, median (25^th-75^th percentiles)

	Before propensity score matching			After propensity score matching			Odds ratio¹
	Sutured valves	Perceval valves	P value	Sutured valves	Perceval valves	P value	Odds ratio¹
Intra-operative mortality	0 (0.0)	0 (0.0)	NA	0 (0.0)	0 (0.0)	NA	NA
In-hospital mortality	16 (2.0)	1 (0.6)	0.197	2 (1.1)	1 (0.6)	0.562	0.50 (0.04-5.55)
< 30 days mortality	23 (2.8)	3 (1.7)	0.403	4 (2.3)	3 (1.7)	0.703	0.73 (0.16-3.35)
Length of CICU stay (days) (n = 917)	1.14 (0.97-2.11)	1.13 (0.98-1.91)	0.543	1.25 (1.00-2.50)	1.13 (0.96-2.00)	0.132	NA
Total length of stay (days) (n = 917)	6.90 (5.31-9.99)	7.08 (5.93-9.90)	0.248	8 (6.00-11.0)	7 (6.00-10.00)	0.315	NA
Post-operative complications
Atrial fibrillation	229 (28.3)	39 (22.4)	0.111	58 (33.3)	39 (22.4)	0.023	0.57 (0.35-0.91)
Pneumonia	152 (18.8)	21 (12.1)	0.030	36 (20.7)	21 (12.1)	0.030	0.49 (0.27-0.90)
Delirium	100 (12.4)	28 (16.1)	0.187	27 (15.5)	28 (16.1)	0.883	1.03 (0.58-1.83)
MI	1 (0.1)	0 (0.0)	0.642	0 (0.0)	0 (0.0)	NA	NA
PPM	19 (2.4)	6 (3.4)	0.405	4 (3.10)	6 (3.4)	0.521	1.50 (0.42-5.44)
VT/VF	9 (1.1)	0 (0.0)	0.162	0 (0.0)	0 (0.0)	NA	0.94 (0.06-15.9)
Pneumothorax	8 (1.0)	1 (0.6)	0.602	1 (0.6)	1 (0.60)	1.000	0.95 (0.06-15.89)
Stroke	25 (3.1)	6 (3.4)	0.808	4 (2.3)	6 (3.4)	0.521	1.51 (0.42-5.47)

¹After matching, adjusted for additive Euroscore. P values for adjusted odds ratios available in Supplementary Table 2.

CICU: Cardiothoracic intensive care unit; MI: Myocardial infarction; PPM: Permanent pace-maker; VT/VF: Ventricular tachycardia/ventricular fibrillation.

Citation: French T, Avtaar Singh SS, Giordano V, Koutsogiannidis CP, Lim KHH, Pessotto R, Zamvar V. Sutureless aortic valve and post-operative atrial fibrillation: Five-year outcomes from a propensity matched cohort study. World J Cardiol 2025; 17(4): 102669
URL: https://www.wjgnet.com/1949-8462/full/v17/i4/102669.htm
DOI: https://dx.doi.org/10.4330/wjc.v17.i4.102669